Enteric Softgel Capsules Market Expected to Reach $3.5 Billion by 2032—Allied Market Research

According to a new report published by Allied Market Research, titled, “Enteric Softgel Capsules Market," The enteric softgel capsules market size was valued at $2.3 billion in 2022, and is estimated to reach $3.5 billion by 2032, growing at a CAGR of 4% from 2023 to 2032.

Enteric softgel capsules are pharmaceutical or nutraceutical dosage forms with a gelatinous shell designed for easy swallowing. These capsules feature an enteric coating, a protective layer that shields their contents from stomach acids. This coating ensures targeted release in the intestine, making enteric softgel capsules ideal for drugs or supplements sensitive to gastric conditions. The capsules facilitate improved bioavailability, minimize gastrointestinal side effects, and cater to diverse pharmaceutical and nutraceutical applications. 

The enteric softgel capsules market is experiencing additional growth due to increased research and development (R&D) efforts aimed at creating drug dosage forms with heightened bioavailability, improved efficacy, and maximum therapeutic activity. This focus on innovation is driving advancements in pharmaceutical formulations, contributing to the overall expansion of the market. Moreover, the adoption of key strategies, particularly notable product launches, is playing a pivotal role in fueling market growth. For instance, in November 2022, Lonza, a preferred partner to the pharmaceutical, biotech and nutraceutical markets, launched an innovative new capsule solution for intestinal (enteric) drug delivery. The Capsugel Enprotect capsule does not disintegrate during stomach transit and only releases its contents in the intestine. Thus, innovation represents a significant leap  offering a more controlled and targeted release of pharmaceutical compounds, and thus exemplifies how strategic product launches contribute to the continued growth and evolution of the enteric softgel capsule market. 

However, limited applicability of enteric coatings for certain formulations and environmental concerns related to the use of gelatin may impact market dynamics. Competition from generic products adds further pressure, emphasizing the need for strategic adaptation amid these challenges.  

On the basis of application, the market is segmented into health supplements and pharmaceuticals. The health supplements segments accounted for the largest share in terms of revenue in 2022 and is anticipated to register the fastest growing CAGR in the forecast period owing to growing emphasis on preventive healthcare, fitness trends, and a proactive approach to well-being. Consumers are increasingly turning to health supplements to address nutritional gaps, support immune function, and promote overall vitality. With a rising focus on a healthy lifestyle and the pursuit of personalized wellness solutions, the demand for health supplements is expected to persist. 

On the basis of distribution channel, the market is segmented into supermarkets & hypermarkets, pharmacy & drug stores, and online providers. The pharmacy & drug store segment accounted for the largest share in terms of revenue in 2022 and is expected to maintain its lead during the forecast period owing to its widespread accessibility, offering a convenient and trusted source for prescription medications, over-the-counter drugs, and various healthcare essentials. As essential healthcare providers, pharmacies play a crucial role in the healthcare ecosystem, providing essential services, medication counseling, and health advice. However, the online provider segment is expected to exhibit the fastest CAGR growth during the forecast period owing to the increasing reliance on online platforms for purchasing goods and services, including health-related products. The convenience of browsing, comparing, and purchasing health supplements and other products from the comfort of one's home, coupled with the availability of a wide range of choices, contributes to the sustained popularity of online providers.   

On the basis of region, North America has the largest share in terms of revenue in 2022 and is expected to maintain its lead during the forecast period owing to a well-established healthcare infrastructure and high healthcare expenditure, supporting the demand for various health-related products and services. Additionally, the region experiences a consistently high level of awareness and emphasis on health and wellness among its population, driving the consumption of health supplements and related products. However, Asia-Pacific is expected to exhibit the fastest growth during the forecast period, owing to surge in urbanization and change in dietary habits, leading to an increased focus on health and nutrition. As urban populations grow, there is a greater prevalence of sedentary lifestyles, creating a demand for supplements to compensate for potential nutritional deficiencies.  

Key findings of the study  

• On the basis of application, the health supplements segment dominated the market in terms of revenue in 2022 and is anticipated to grow at the fastest CAGR during the forecast period.  

• On the basis of distribution channel, the pharmacy & drug store segment dominated the market in terms of revenue in 2022. However, the online provider segment is anticipated to grow at the fastest CAGR during the forecast period.   

• Region wise, North America generated the largest revenue in 2022. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.